Patents by Inventor Morten Elde

Morten Elde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200332352
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 13, 2019
    Publication date: October 22, 2020
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN
  • Patent number: 10787702
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: September 29, 2020
    Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSø—NORGES ARKTISKE UNIVERSITET
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Publication number: 20200071753
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 13, 2019
    Publication date: March 5, 2020
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN
  • Patent number: 10415082
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: September 17, 2019
    Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSø—NORGES ARKTISKE UNIVERSITET
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Publication number: 20180363042
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 28, 2018
    Publication date: December 20, 2018
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Patent number: 10087483
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID No. 1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCI, pH 8.5 at 25° C., 50 mM KCI and 5 mM MgCI2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: October 2, 2018
    Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSØ—NORGES ARKTISKE UNIVERSITET
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Publication number: 20170233800
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID No. 1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 19, 2015
    Publication date: August 17, 2017
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN
  • Patent number: 9133447
    Abstract: The invention provides methods of removing nucleic acid contamination from reverse transcription reactions and hot-start PCR, wherein said hot-start PCR is a barrier hot-start PCR set up and/or involves a hot-start DNA polymerase, which methods comprise use of a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA. The invention further provides a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA, nucleic acids encoding said DNase and kits or compositions comprising said DNase or said nucleic acid.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: September 15, 2015
    Assignee: Biotec Pharmacon ASA
    Inventors: Olav Lanes, Morten Elde, Dag Rune Gjellesvik
  • Publication number: 20140093938
    Abstract: The invention provides methods of removing nucleic acid contamination from reverse transcription reactions and hot-start PCR, wherein said hot-start PCR is a barrier hot-start PCR set up and/or involves a hot-start DNA polymerase, which methods comprise use of a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA. The invention further provides a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA, nucleic acids encoding said DNase and kits or compositions comprising said DNase or said nucleic acid.
    Type: Application
    Filed: September 25, 2013
    Publication date: April 3, 2014
    Applicant: BIOTEC PHARMACON ASA
    Inventors: Olav Lanes, Morten Elde, Dag Rune Gjellesvik
  • Patent number: 8551753
    Abstract: The invention provides methods of removing nucleic acid contamination from reverse transcription reactions and hot-start PCR, wherein said hot-start PCR is a barrier hot-start PCR set up and/or involves a hot-start DNA polymerase, which methods comprise use of a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA. The invention further provides a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA, nucleic acids encoding said DNase and kits or compositions comprising said DNase or said nucleic acid.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: October 8, 2013
    Assignee: Biotec Pharmacon ASA
    Inventors: Olav Lanes, Morten Elde, Dag Rune Gjellesvik
  • Publication number: 20110020878
    Abstract: The invention provides methods of removing nucleic acid contamination from reverse transcription reactions and hot-start PCR, wherein said hot-start PCR is a barrier hot-start PCR set up and/or involves a hot-start DNA polymerase, which methods comprise use of a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA. The invention further provides a DNase that is substantially irreversibly inactivated by heating at a temperature of about 50° C. for 5 minutes, and that is substantially specific for double stranded DNA, nucleic acids encoding said DNase and kits or compositions comprising said DNase or said nucleic acid.
    Type: Application
    Filed: July 21, 2010
    Publication date: January 27, 2011
    Applicant: BIOTEC PHARMACON ASA
    Inventors: Olav Lanes, Morten Elde, Dag Rune Gjellesvik